Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

SyntheticMR

1.25 SEK

-6.74 %

Less than 1K followers

SYNT

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-6.74 %
-48.12 %
-52.66 %
-63.38 %
-71.05 %
-73.66 %
-96.08 %
-95.98 %
-43.96 %

SyntheticMR is a medical technology company that is active in the development of analysis and imaging methods. The technology is mainly used for magnetic resonance imaging (MRI) in healthcare. The technology is based on a quantification-based method that aims to increase the efficiency and quality of MRI examinations. The company was founded in 2007 and is headquartered in Linköping.

Read more
Market cap
74.15M SEK
Turnover
65.92K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17.2.
2026

Annual report '25

12.5.
2026

Interim report Q1'26

12.5.
2026

General meeting '26

All
Press releases
ShowingAll content types
Regulatory press release11/28/2025, 7:00 AM

SyntheticMR AB: Interim report July - September 2025

SyntheticMR
Regulatory press release11/25/2025, 6:07 PM

SyntheticMR AB (publ) postpones the interim report for the third quarter of 2025

SyntheticMR
Regulatory press release11/22/2025, 2:53 PM

Marcel Warntjes resigns from the Board of Directors of SyntheticMR AB (publ)

SyntheticMR

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Press release10/29/2025, 7:50 AM

SyntheticMR AB: Nomination Committee appointed for the 2026 Annual General Meeting in SyntheticMR

SyntheticMR
Regulatory press release9/1/2025, 6:18 AM

Lena Åredal Assumes Role as CEO of SyntheticMR AB (publ)

SyntheticMR
Regulatory press release8/26/2025, 6:07 AM

SyntheticMR AB: Interim report April- June 2025

SyntheticMR
Regulatory press release6/13/2025, 6:56 AM

Lena Åredal Appointed New CEO of SyntheticMR AB (publ)

SyntheticMR
Press release6/3/2025, 8:30 AM

SyntheticMR AB: New Multicenter Study Demonstrates SyMRI's Potential to Transform Clinical Neuroimaging Workflows

SyntheticMR
Regulatory press release5/20/2025, 4:59 PM

Report from Annual General Meeting in SyntheticMR AB (publ)

SyntheticMR
Regulatory press release5/20/2025, 6:18 AM

SyntheticMR AB: Interim report January - March 2025

SyntheticMR
Regulatory press release4/22/2025, 6:48 AM

Notice to attend the annual general meeting of SyntheticMR AB (publ)

SyntheticMR
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.